BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Margine I, Krammer F. Animal models for influenza viruses: implications for universal vaccine development. Pathogens 2014;3:845-74. [PMID: 25436508 DOI: 10.3390/pathogens3040845] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Santana CM, Gauger P, Vetger A, Magstadt D, Kim DS, Shrestha D, Charavaryamath C, Rumbeiha WK. Ambient hydrogen sulfide exposure increases the severity of influenza A virus infection in swine. Arch Environ Occup Health 2021;:1-13. [PMID: 33750267 DOI: 10.1080/19338244.2021.1896986] [Reference Citation Analysis]
2 Chua SCJH, Tan HQ, Engelberg D, Lim LHK. Alternative Experimental Models for Studying Influenza Proteins, Host-Virus Interactions and Anti-Influenza Drugs. Pharmaceuticals (Basel) 2019;12:E147. [PMID: 31575020 DOI: 10.3390/ph12040147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
3 Lemaitre J, Naninck T, Delache B, Creppy J, Huber P, Holzapfel M, Bouillier C, Contreras V, Martinon F, Kahlaoui N, Pascal Q, Tricot S, Ducancel F, Vecellio L, Le Grand R, Maisonnasse P. Non-human primate models of human respiratory infections. Mol Immunol 2021;135:147-64. [PMID: 33895579 DOI: 10.1016/j.molimm.2021.04.010] [Reference Citation Analysis]
4 Oh DY, Hurt AC. Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness. Front Microbiol 2016;7:80. [PMID: 26870031 DOI: 10.3389/fmicb.2016.00080] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
5 Ryan KA, Slack GS, Marriott AC, Kane JA, Whittaker CJ, Silman NJ, Carroll MW, Gooch KE. Cellular immune response to human influenza viruses differs between H1N1 and H3N2 subtypes in the ferret lung. PLoS One 2018;13:e0202675. [PMID: 30192789 DOI: 10.1371/journal.pone.0202675] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
6 Belser JA, Johnson A, Pulit-Penaloza JA, Pappas C, Pearce MB, Tzeng WP, Hossain MJ, Ridenour C, Wang L, Chen LM, Wentworth DE, Katz JM, Maines TR, Tumpey TM. Pathogenicity testing of influenza candidate vaccine viruses in the ferret model. Virology 2017;511:135-41. [PMID: 28846898 DOI: 10.1016/j.virol.2017.08.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
7 Nabel GJ, Shiver JW. All for one and one for all to fight flu. Nature 2019;565:29-31. [DOI: 10.1038/d41586-018-07654-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Qu XY, Li QJ, Zhang HM, Zhang XJ, Shi PH, Zhang XJ, Yang J, Zhou Z, Wang SQ. Protective effects of phillyrin against influenza A virus in vivo. Arch Pharm Res 2016;39:998-1005. [PMID: 27323762 DOI: 10.1007/s12272-016-0775-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
9 Krishnakumar V, Durairajan SSK, Alagarasu K, Li M, Dash AP. Recent Updates on Mouse Models for Human Immunodeficiency, Influenza, and Dengue Viral Infections. Viruses 2019;11:E252. [PMID: 30871179 DOI: 10.3390/v11030252] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
10 Hao X, Li F, Lv Q, Xu Y, Han Y, Gao H. Establishment of BALB/C mouse models of influenza A H1N1 aerosol inhalation. J Med Virol 2019;91:1918-29. [DOI: 10.1002/jmv.25550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Kiseleva I, Rekstin A, Al Farroukh M, Bazhenova E, Katelnikova A, Puchkova L, Rudenko L. Non-Mouse-Adapted H1N1pdm09 Virus as a Model for Influenza Research. Viruses 2020;12:E590. [PMID: 32485821 DOI: 10.3390/v12060590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 de Jonge J, Isakova-Sivak I, van Dijken H, Spijkers S, Mouthaan J, de Jong R, Smolonogina T, Roholl P, Rudenko L. H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets. Mol Ther 2016;24:991-1002. [PMID: 26796670 DOI: 10.1038/mt.2016.23] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
13 Bernocchi B, Carpentier R, Betbeder D. Nasal nanovaccines. Int J Pharm 2017;530:128-38. [PMID: 28698066 DOI: 10.1016/j.ijpharm.2017.07.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
14 Elderfield RA, Parker L, Stilwell P, Roberts KL, Schepelmann S, Barclay WS. Ferret airway epithelial cell cultures support efficient replication of influenza B virus but not mumps virus. J Gen Virol 2015;96:2092-8. [PMID: 25953915 DOI: 10.1099/vir.0.000176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
15 Moore KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, Bresee JS, Friede MH, Gellin BG, Golding JP, Hart PJ, Moen A, Weller CL, Osterholm MT; Influenza Vaccines R&D Roadmap Taskforce. A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future. Vaccine 2021;39:6573-84. [PMID: 34602302 DOI: 10.1016/j.vaccine.2021.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Willis E, Parkhouse K, Krammer F, Hensley SE. Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States. Vaccine 2016;34:5483-7. [PMID: 27670073 DOI: 10.1016/j.vaccine.2016.09.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Sarkar S, Heise MT. Mouse Models as Resources for Studying Infectious Diseases. Clin Ther 2019;41:1912-22. [PMID: 31540729 DOI: 10.1016/j.clinthera.2019.08.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
18 Meliopoulos VA, Karlsson EA, Schultz-cherry S. What can imaging tell us about influenza virus transmission and protection? Future Virology 2016;11:583-90. [DOI: 10.2217/fvl-2016-0062] [Reference Citation Analysis]
19 de Jonge J, van Dijken H, de Heij F, Spijkers S, Mouthaan J, de Jong R, Roholl P, Adami EA, Akamatsu MA, Ho PL, Brunner L, Collin N, Friede M, Ferreira JA, Luytjes W. H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets. NPJ Vaccines 2020;5:38. [PMID: 32411401 DOI: 10.1038/s41541-020-0187-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
20 Arsenović-Ranin N, Petrović R, Živković I, Bufan B, Stoiljković V, Leposavić G. Influence of aging on germinal centre reaction and antibody response to inactivated influenza virus antigens in mice: sex-based differences. Biogerontology 2019;20:475-96. [PMID: 31049769 DOI: 10.1007/s10522-019-09811-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Renukaradhya GJ, Narasimhan B, Mallapragada SK. Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation. J Control Release 2015;219:622-31. [PMID: 26410807 DOI: 10.1016/j.jconrel.2015.09.047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
22 Lin YJ, Shih YJ, Chen CH, Fang CT. Aluminum salts as an adjuvant for pre-pandemic influenza vaccines: a meta-analysis. Sci Rep 2018;8:11460. [PMID: 30061656 DOI: 10.1038/s41598-018-29858-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
23 Wang X, Ma T, Yu H, Chen Z, Zhu B, Chen W, Sun S, Li Z. Purification of sialoglycoproteins from bovine milk using serotonin-functionalized magnetic particles and their application against influenza A virus. Food Funct 2020;11:6911-20. [PMID: 32691813 DOI: 10.1039/d0fo01447h] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kiseleva IV, Farroukh MA, Skomorokhova EA, Rekstin AR, Bazhenova EA, Magazenkova DN, Orlov IA, Rudenko LG, Broggini M, Puchkova LV. Anti-Influenza Effect of Nanosilver in a Mouse Model. Vaccines (Basel) 2020;8:E679. [PMID: 33202939 DOI: 10.3390/vaccines8040679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Lin CY, Chia MY, Chen PL, Yeh CT, Cheng MC, Su IJ, Lee MS. Assessment of pathogenicity and antigenicity of American lineage influenza H5N2 viruses in Taiwan. Virology 2017;508:159-63. [PMID: 28549236 DOI: 10.1016/j.virol.2017.05.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
26 Petrović R, Bufan B, Arsenović-Ranin N, Živković I, Minić R, Radojević K, Leposavić G. Mouse strain and sex as determinants of immune response to trivalent influenza vaccine. Life Sci 2018;207:117-26. [PMID: 29859986 DOI: 10.1016/j.lfs.2018.05.056] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
27 DiPiazza AT, Richards KA, Liu WC, Albrecht RA, Sant AJ. Analyses of Cellular Immune Responses in Ferrets Following Influenza Virus Infection. Methods Mol Biol 2018;1836:513-30. [PMID: 30151589 DOI: 10.1007/978-1-4939-8678-1_24] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
28 Schmidt A, Lapuente D. T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine. Viruses 2021;13:199. [PMID: 33525620 DOI: 10.3390/v13020199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
29 Tundup S, Kandasamy M, Perez JT, Mena N, Steel J, Nagy T, Albrecht RA, Manicassamy B. Endothelial cell tropism is a determinant of H5N1 pathogenesis in mammalian species. PLoS Pathog 2017;13:e1006270. [PMID: 28282445 DOI: 10.1371/journal.ppat.1006270] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
30 Yang W, Lambertz RLO, Punyadarsaniya D, Leist SR, Stech J, Schughart K, Herrler G, Wu NH, Meng F. Increased virulence of a PB2/HA mutant of an avian H9N2 influenza strain after three passages in porcine differentiated airway epithelial cells. Vet Microbiol 2017;211:129-34. [PMID: 29102108 DOI: 10.1016/j.vetmic.2017.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
31 Xu S, Li X, Yang J, Wang Z, Jia Y, Han L, Wang L, Zhu Q. Comparative Pathogenicity and Transmissibility of Pandemic H1N1, Avian H5N1, and Human H7N9 Influenza Viruses in Tree Shrews. Front Microbiol 2019;10:2955. [PMID: 31921093 DOI: 10.3389/fmicb.2019.02955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
32 Essaidi-Laziosi M, Brito F, Benaoudia S, Royston L, Cagno V, Fernandes-Rocha M, Piuz I, Zdobnov E, Huang S, Constant S, Boldi MO, Kaiser L, Tapparel C. Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures. J Allergy Clin Immunol 2018;141:2074-84. [PMID: 28797733 DOI: 10.1016/j.jaci.2017.07.018] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 11.4] [Reference Citation Analysis]
33 Myers MA, Smith AP, Lane LC, Moquin DJ, Aogo R, Woolard S, Thomas P, Vogel P, Smith AM. Dynamically linking influenza virus infection kinetics, lung injury, inflammation, and disease severity. Elife 2021;10:e68864. [PMID: 34282728 DOI: 10.7554/eLife.68864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Kalhoro DH, Gao S, Xie X, Liang S, Luo S, Zhao Y, Liu Y. Canine influenza virus coinfection with Staphylococcus pseudintermedius enhances bacterial colonization, virus load and clinical presentation in mice. BMC Vet Res 2016;12:87. [PMID: 27259293 DOI: 10.1186/s12917-016-0708-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
35 Park S, Il Kim J, Lee I, Bae JY, Yoo K, Nam M, Kim J, Sook Park M, Song KJ, Song JW, Kee SH, Park MS. Adaptive mutations of neuraminidase stalk truncation and deglycosylation confer enhanced pathogenicity of influenza A viruses. Sci Rep 2017;7:10928. [PMID: 28883554 DOI: 10.1038/s41598-017-11348-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
36 Rodriguez L, Nogales A, Martínez-Sobrido L. Influenza A Virus Studies in a Mouse Model of Infection. J Vis Exp 2017. [PMID: 28930978 DOI: 10.3791/55898] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
37 Navratil N. Ferrets that help fight the flu. Lab Anim (NY) 2016;45:440-1. [PMID: 27763617 DOI: 10.1038/laban.1145] [Reference Citation Analysis]
38 Kurskaya OG, Sharshov KA, Alekseev AY, Gulyaeva MA, Shestopalov AM, Shestopalova LV, Ignatev GM, Shkurupiy VA. The Study in Animal Models of Local Action, Acute and Chronic Toxicity of Inactivated Influenza Vaccine Ultriks in Syringe. Epidemiology and Vaccine Prevention 2015;14:66-73. [DOI: 10.31631/2073-3046-2015-14-3-66-73] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Sreenivasan C, Thomas M, Sheng Z, Hause BM, Collin EA, Knudsen DE, Pillatzki A, Nelson E, Wang D, Kaushik RS, Li F. Replication and Transmission of the Novel Bovine Influenza D Virus in a Guinea Pig Model. J Virol 2015;89:11990-2001. [PMID: 26378161 DOI: 10.1128/JVI.01630-15] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
40 Wang X, Yue L, Dang L, Yang J, Chen Z, Wang X, Shu J, Li Z. Role of sialylated glycans on bovine lactoferrin against influenza virus. Glycoconj J 2021. [PMID: 34779975 DOI: 10.1007/s10719-021-10029-5] [Reference Citation Analysis]
41 DiPiazza A, Richards K, Batarse F, Lockard L, Zeng H, García-Sastre A, Albrecht RA, Sant AJ. Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection. J Virol 2016;90:7991-8004. [PMID: 27356897 DOI: 10.1128/JVI.01001-16] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
42 Quan FS, Basak S, Chu KB, Kim SS, Kang SM. Progress in the development of virus-like particle vaccines against respiratory viruses. Expert Rev Vaccines 2020;19:11-24. [PMID: 31903811 DOI: 10.1080/14760584.2020.1711053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
43 Liu WC, Nachbagauer R, Krammer F, Albrecht RA. Assessment of Influenza Virus Hemagglutinin Stalk-Specific Antibody Responses. Methods Mol Biol 2018;1836:487-511. [PMID: 30151588 DOI: 10.1007/978-1-4939-8678-1_23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
44 Leymarie O, Meyer L, Hervé PL, Da Costa B, Delmas B, Chevalier C, Le Goffic R. Host Response Comparison of H1N1- and H5N1-Infected Mice Identifies Two Potential Death Mechanisms. Int J Mol Sci 2017;18:E1631. [PMID: 28749409 DOI: 10.3390/ijms18081631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Roubidoux EK, Schultz-Cherry S. Animal Models Utilized for the Development of Influenza Virus Vaccines. Vaccines (Basel) 2021;9:787. [PMID: 34358203 DOI: 10.3390/vaccines9070787] [Reference Citation Analysis]
46 Kongchanagul A, Samnuan K, Wirachwong P, Surichan S, Puthavathana P, Pitisuttithum P, Boonnak K. A live attenuated H5N2 prime- inactivated H5N1 boost vaccination induces influenza virus hemagglutinin stalk specific antibody responses. Vaccine 2020;38:852-8. [PMID: 31708176 DOI: 10.1016/j.vaccine.2019.10.084] [Reference Citation Analysis]
47 Riese P, Trittel S, Schulze K, Guzmán CA. Rodents as pre-clinical models for predicting vaccine performance in humans. Expert Review of Vaccines 2015;14:1213-25. [DOI: 10.1586/14760584.2015.1074043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
48 Bhat SV, Price JDW, Dahms TES. AFM-Based Correlative Microscopy Illuminates Human Pathogens. Front Cell Infect Microbiol 2021;11:655501. [PMID: 34026660 DOI: 10.3389/fcimb.2021.655501] [Reference Citation Analysis]
49 McNee A, Smith TRF, Holzer B, Clark B, Bessell E, Guibinga G, Brown H, Schultheis K, Fisher P, Ramos S, Nunez A, Bernard M, Graham S, Martini V, Chrun T, Xiao Y, Kash JC, Taubenberger JK, Elliott S, Patel A, Beverley P, Rijal P, Weiner DB, Townsend A, Broderick KE, Tchilian E. Establishment of a Pig Influenza Challenge Model for Evaluation of Monoclonal Antibody Delivery Platforms. J Immunol 2020;205:648-60. [PMID: 32591390 DOI: 10.4049/jimmunol.2000429] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
50 Adler-Moore JP, Ernst W, Kim H, Ward N, Chiang SM, Do T, Fujii G. Monomeric M2e antigen in VesiVax® liposomes stimulates protection against type a strains of influenza comparable to liposomes with multimeric forms of M2e. J Liposome Res 2017;27:210-20. [PMID: 28922045 DOI: 10.1080/08982104.2017.1381708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
51 Kubo M, Miyauchi K. Breadth of Antibody Responses during Influenza Virus Infection and Vaccination. Trends Immunol 2020;41:394-405. [PMID: 32265127 DOI: 10.1016/j.it.2020.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
52 Progatzky F, Jha A, Wane M, Thwaites RS, Makris S, Shattock RJ, Johansson C, Openshaw PJ, Bugeon L, Hansel TT, Dallman MJ. Induction of innate cytokine responses by respiratory mucosal challenge with R848 in zebrafish, mice, and humans. J Allergy Clin Immunol 2019;144:342-345.e7. [PMID: 31002833 DOI: 10.1016/j.jaci.2019.04.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
53 Belser JA, Eckert AM, Huynh T, Gary JM, Ritter JM, Tumpey TM, Maines TR. A Guide for the Use of the Ferret Model for Influenza Virus Infection. Am J Pathol 2020;190:11-24. [PMID: 31654637 DOI: 10.1016/j.ajpath.2019.09.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
54 Sell S, McKinstry KK, Strutt TM. Mouse Models Reveal Role of T-Cytotoxic and T-Reg Cells in Immune Response to Influenza: Implications for Vaccine Design. Viruses 2019;11:E52. [PMID: 30641955 DOI: 10.3390/v11010052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
55 Gerdts V, Wilson HL, Meurens F, van Drunen Littel - van den Hurk S, Wilson D, Walker S, Wheler C, Townsend H, Potter AA. Large Animal Models for Vaccine Development and Testing. ILAR Journal 2015;56:53-62. [DOI: 10.1093/ilar/ilv009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
56 Manickam C, Shah SV, Lucar O, Ram DR, Reeves RK. Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections. Front Immunol 2018;9:2862. [PMID: 30568659 DOI: 10.3389/fimmu.2018.02862] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
57 Wagar LE, DiFazio RM, Davis MM. Advanced model systems and tools for basic and translational human immunology. Genome Med 2018;10:73. [PMID: 30266097 DOI: 10.1186/s13073-018-0584-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 9.8] [Reference Citation Analysis]
58 Estrin MA, Hussein ITM, Puryear WB, Kuan AC, Artim SC, Runstadler JA. Host-directed combinatorial RNAi improves inhibition of diverse strains of influenza A virus in human respiratory epithelial cells. PLoS One 2018;13:e0197246. [PMID: 29775471 DOI: 10.1371/journal.pone.0197246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
59 Starbæk SMR, Brogaard L, Dawson HD, Smith AD, Heegaard PMH, Larsen LE, Jungersen G, Skovgaard K. Animal Models for Influenza A Virus Infection Incorporating the Involvement of Innate Host Defenses: Enhanced Translational Value of the Porcine Model. ILAR Journal 2018;59:323-37. [DOI: 10.1093/ilar/ily009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
60 Jeong JH, Kim EH, Lloren KKS, Kwon JJ, Kwon HI, Ahn SJ, Kim YI, Choi WS, Si YJ, Lee OJ, Han HJ, Baek YH, Song MS, Choi YK, Kim CJ. Preclinical evaluation of the efficacy of an H5N8 vaccine candidate (IDCDC-RG43A) in mouse and ferret models for pandemic preparedness. Vaccine 2019;37:484-93. [PMID: 30502069 DOI: 10.1016/j.vaccine.2018.11.064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
61 Nguyen TQ, Rollon R, Choi YK. Animal Models for Influenza Research: Strengths and Weaknesses. Viruses 2021;13:1011. [PMID: 34071367 DOI: 10.3390/v13061011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Brogaard L, Heegaard PM, Larsen LE, Mortensen S, Schlegel M, Dürrwald R, Skovgaard K. Late regulation of immune genes and microRNAs in circulating leukocytes in a pig model of influenza A (H1N2) infection. Sci Rep 2016;6:21812. [PMID: 26893019 DOI: 10.1038/srep21812] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
63 Rattan A, White CL, Nelson S, Eismann M, Padilla-quirarte H, Glover MA, Dileepan T, Marathe BM, Govorkova EA, Webby RJ, Richards KA, Sant AJ. Development of a Mouse Model to Explore CD4 T Cell Specificity, Phenotype, and Recruitment to the Lung after Influenza B Infection. Pathogens 2022;11:251. [DOI: 10.3390/pathogens11020251] [Reference Citation Analysis]
64 Belser JA, Pulit-Penaloza JA, Maines TR. Ferreting Out Influenza Virus Pathogenicity and Transmissibility: Past and Future Risk Assessments in the Ferret Model. Cold Spring Harb Perspect Med 2020;10:a038323. [PMID: 31871233 DOI: 10.1101/cshperspect.a038323] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
65 Farrukee R, Tai CM, Oh DY, Anderson DE, Gunalan V, Hibberd M, Lau GY, Barr IG, Messling VV, Maurer-Stroh S, Hurt AC. Utilising animal models to evaluate oseltamivir efficacy against influenza A and B viruses with reduced in vitro susceptibility. PLoS Pathog 2020;16:e1008592. [PMID: 32555740 DOI: 10.1371/journal.ppat.1008592] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Bhide Y, Dong W, Meijerhof T, de Vries-Idema J, Niesters HG, Huckriede A. Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination. Immun Inflamm Dis 2020;8:279-91. [PMID: 32319216 DOI: 10.1002/iid3.303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
67 Edmans M, McNee A, Porter E, Vatzia E, Paudyal B, Martini V, Gubbins S, Francis O, Harley R, Thomas A, Burt R, Morgan S, Fuller A, Sewell A, Charleston B, Bailey M, Tchilian E. Magnitude and Kinetics of T Cell and Antibody Responses During H1N1pdm09 Infection in Inbred Babraham Pigs and Outbred Pigs. Front Immunol 2020;11:604913. [PMID: 33603740 DOI: 10.3389/fimmu.2020.604913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
68 Van Reeth K. The post-2009 influenza pandemic era: time to revisit antibody immunodominance. J Clin Invest 2018;128:4751-4. [PMID: 30295644 DOI: 10.1172/JCI124151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
69 Niyibizi N, Schamel J, Frew PM. Neighborhood Influences on Seasonal Influenza Vaccination among Older African Americans in Atlanta, Georgia. J Immunol Tech Infect Dis 2016;5:139. [PMID: 28553672 DOI: 10.4172/2329-9541.1000139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
70 McMillan CLD, Cheung STM, Modhiran N, Barnes J, Amarilla AA, Bielefeldt-Ohmann H, Lee LYY, Guilfoyle K, van Amerongen G, Stittelaar K, Jakon V, Lebas C, Reading P, Short KR, Young PR, Watterson D, Chappell KJ. Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses. NPJ Vaccines 2021;6:135. [PMID: 34750396 DOI: 10.1038/s41541-021-00395-4] [Reference Citation Analysis]
71 Tu L, Zhou P, Li L, Li X, Hu R, Jia K, Sun L, Yuan Z, Li S. Evaluation of protective efficacy of three novel H3N2 canine influenza vaccines. Oncotarget 2017;8:98084-93. [PMID: 29228675 DOI: 10.18632/oncotarget.21104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]